Miriam Machado retweeted
Sharing our Consensus report @SENefrologia @SLANH_ @SociedadSeedo on Obesity related kidney disease. Proposal for a new classification - Kidney International kidney-international.org/art…
Fighting together against #obesity & #kidneydisease
Miriam Machado retweeted
𝐑𝐓𝐗 treatment in
𝐦𝐞𝐦𝐛𝐫𝐚𝐧𝐨𝐮𝐬 𝐧𝐞𝐩𝐡𝐫𝐨𝐩𝐚𝐭𝐡𝐲 excellent 𝐥𝐨𝐧𝐠-𝐭𝐞𝐫𝐦 renal survival‼️ Giving New Evidence‼️ 🙏🙏🙏@MayoClinicNeph @mvargas07 @SethiRenalPath @fervenzafernan1 @mimamed @LadanZand @ilariokidn @vallhebron
kireports.org/article/S2468-…
Miriam Machado retweeted
The picture is similar that than one from #2021 pubmed.ncbi.nlm.nih.gov/3392… @ClaraGCarro @shbermejo @maazancot @AnderVerg @vallhebron @SENefrologia @NefrologiaVH
Miriam Machado retweeted
nature.com/articles/s41574-0… Obesity and the kidney: mechanistic links and therapeutic advances @SociedadSeedo @SENefrologia @jorgericof @jlgorriz @PepaSolerR
Miriam Machado retweeted
Miriam Machado retweeted
Ya están aquí los 4 pilares del tratamiento de la ERC. El cambio de paradigma en directo desde #Estocolmo @ERAkidney @SENefrologia @SLANH_
Miriam Machado retweeted
Replying to @CKJsocial
@CKJsocial Are we ready for an adipocentric approach in people living with T2D and CKD? Dysfunctional Adipose Tissue Approach #DATA #CKM
#endopower & #nephropower🇪🇸 @sociedadSEEN @SEDiabetes @SENefrologia @SEMERGENap @EASDnews @IntDiabetesFed @ERAKidney doi.org/10.1093/ckj/sfae039
Miriam Machado retweeted
#HappyBirthday 🎉🎂🎊🎉🥳Prof. @SethiRenalPath Enjoy your day!! @HerrmannMd @fervenzafernan1 @MPAlexanderMD @boulboulasana #Majito #danielavalencia
Miriam Machado retweeted
#celebrating #book #publication Thanks to @BayerPharma @EdizioniMinerva & all the #authors 🙌🙌🙌 #teamwork
Miriam Machado retweeted
Congratulations to my friend @fervenzafernan1 for receiving the Mayo Clinic Distinguished Clinician Award at the 2023 annual staff meeting. Most deserving. Happy and proud.
Miriam Machado retweeted
Our Mayo Clinic Membranous Nephropathy Consensus Report is finally out.
A year in the making.
The manuscript brings together the recent advances in MN.
I am very thankful to all my collaborators.
@MayoClinicNeph @MayoClinic @MayoClinicPath
sciencedirect.com/science/ar… – at Minnesota, USA
Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification - ScienceDirect
Why do patterns matter?
@PepaSolerR @jorgericof sciencedirect.com/science/ar…
Which one?
Let’s try a baseline thinking.
Thanks, friends @jorgericof @PepaSolerR
GFR decline and kidney endpoints f
#RCT What is the best one?? Do we have a clue? @jorgericof @mimamed @ISNkidneycare @Kidney_Int @SENefrologia @senjoven @georgeinstitute @brendonneuen @Heerspink79 @jlgorriz @FrederikPersson @P_Rossing @vallhebron @SLANH_
kidney-international.org/art…
Miriam Machado retweeted
GFR decline and kidney endpoints f
#RCT What is the best one?? Do we have a clue? @jorgericof @mimamed @ISNkidneycare @Kidney_Int @SENefrologia @senjoven @georgeinstitute @brendonneuen @Heerspink79 @jlgorriz @FrederikPersson @P_Rossing @vallhebron @SLANH_
kidney-international.org/art…
Miriam Machado retweeted
Todos @ISNkidneycare @ynptweets @sen @SLANH_ invitados!! Pasemos un buen rato aprendiendo juntos el próximo #sabado @vallhebron @NefrologiaVH @VHIR_ @onconeph @onconefrologia
No te pierdas este sábado el seminario:
“¿Cuándo biopsiar a un paciente con FRA en tratamiento con inmunoterapia?”
🗓️ 29 de Julio de 2023
🕘 9:00 am CDMX
👩⚕️ Dra. María José Soler @PepaSolerR 🇪🇸
Zoom ID: 863 6358 3637
Pass: 343 190
#GlomConILA #GlomConAmor #MeGusta
Miriam Machado retweeted
A kidney-centric view of pre-eclampsia through the kidney-placental bidirectional lens @GarovicVesna @Kidney_Int #MayoClinicKidney sciencedirect.com/science/ar…
Dr @PepaSolerR inspiring Latin America to create carriorrenal clinics! @SENefrologia @MartaCoboMarcos @maazancot @anamen_81
































